Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983
Mental Disorders From Low-Dose Bromocriptine
NEJM 305:173, Pearson,K.D., 1981
Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979
Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983
Bromocriptine-induced psychosis in acromegaly
BMJ 285:1315, Lefeuvre,C.M.,et al, 1982
Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977